Israel Cancer Research Fund (ICRF)’s Post

Today is #StandUpToCancerDay, a day dedicated to accelerating groundbreaking cancer research, increasing cancer screenings, and ensuring equity in cancer care and clinical trials. Together, we can make a difference in finding a cure. Learn more about getting involved at https://hubs.li/Q021CKQ30. #StandUpToCancer #SU2C

This article, written by Ben Hargreaves at BioSpace, describes the past, present, and future advances in the cancer vaccine field. Slide to discover how the science behind these advances works and what we can expect for the future of immunotherapy. Full article here:  https://lnkd.in/gimAaACZ

Newly published results reveal a significant proportion of early-stage HR+ breast cancer survivors may be over- or undertreated without the Breast Cancer Index test. Learn more at https://bit.ly/43bfab2.

📚 Knowledge is the first step towards change. Explore our blog post on addressing disparities in ovarian cancer clinical trial participation. Together, we can close the gap. Recent Study Findings: https://lnkd.in/eFjCKAQm #KnowledgeIsPower #HealthDisparities #OvarianCancer #CancerResearch

The #SITC 2024 Industry Program, Beyond Checkpoint Inhibitors: New #Immuno-oncology Modalities and Approaches, will advance the science and application of #cancer #immunotherapy and address clinical and scientific considerations combining these modalities with other cancer therapies. This program will consist of three sessions: - Session I: Emerging - What's Next - Promising New Modalities - Session II: Pre-Clinical and Translational - Session III: Putting New Modalities into Practice For more information and to register for the SITC Industry Program, visit: sitcancer.org/2024

Unraveling the Mysteries! Working with the top researchers at UCLA, CancerVAX is delving deep into the possibilities of safer and more effective cancer treatments through targeted immunotherapy. To find out how, visit our website linked in our bio. #Cancer #UCLA #Research #Innovation #MedNews

Watch article on The Lancet Global Commission's CONCORD program on #Cancer – how to harness the value of long-term scientific collaboration to develop effective policies, and how cancer registries provide actionable evidence to shape cancer strategy cancer in different contexts. https://lnkd.in/gG7j5uXu

In honor of #WorldLungCancerDay, we are joining leaders around the world in raising awareness of the importance cancer research plays in creating a better future for patients. At Abdera, we are purpose-built to attack cancer, utilizing advanced antibody engineering with radiotherapeutics to selectively deliver therapeutic levels of radioisotope to #cancer cells. Learn more about our approach and how we are shaping a better outcome for those in need here: https://lnkd.in/gR5GcxDa

It's not too late to register for this week's webinar, Oncology 2050: Have We Been Thinking About the Management of Cancer in the Right Way? Join us as we dive into the future of oncology, redefining treatment strategies, advancing AI, and more. Register at https://buff.ly/4ewD8CF Hear from our panel of experts, including Axel Hoos, Peter Sandor, EVP, Astellas Pharma US, and Lumanity's Jeff Bockman, Viraj Parekh, and Dennis Chang. #Oncology #Cancer #CancerProgress #CancerTreatment #AIinCancerTreatment